These results indicate a strong correlation between increased GM1 and aggravated cognitive impairment in APP/PS1 mice, which is consistent with the elevated GM1 levels in the frontal and temporal cerebral cortex of AD patients.[15, 16]. This evidence concerns the gene APP and Alzheimer disease.